proved that upregulated RBM6 in pancreatic cancer may be released into the blood, which could be a candidate and potential serum biomarker for early diagnosis of pancreatic cancer (Duan et al., 2019). This evidence concerns the gene RBM6 and pancreatic neoplasm.